Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Fastenal Company FAST fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Fastenal reported first-quarter FY24 sales growth of 1.9% Y/Y to $1.895 billion, missing the consensus of $1.914 billion. The company's first-quarter EPS was 52 cents, missing the consensus of 53 cents.

Fastenal shares dipped 6.7% to $69.73 on Thursday.

Here are some other stocks moving in today's mid-day session.

Gainers

• Rallybio Corporation RLYB shares climbed 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.
• Rent the Runway, Inc. RENT shares jumped 74.5% to $12.91 after the company reported mixed fourth-quarter financial results and issued guidance.
• Eliem Therapeutics, Inc. ELYM jumped 59.6% to $4.2650. The company announced that it entered into a definitive acquisition agreement to acquire Tenet and it also entered into a securities purchase agreement for a $120 million private placement.
• Akanda Corp. AKAN gained 36% to $0.1632. Akanda, last month, announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry.
• Alpine Immune Sciences, Inc. ALPN rose 36.6% to $64.25 after Vertex entered into an agreement to acquire the company.
• Candel Therapeutics, Inc. CADL surged 29.6% to $6.61 after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer.
• Enliven Therapeutics, Inc. ELVN gained 26% to $24.97. Enliven Therapeutics announced proof of concept data from Phase 1 clinical trial of ELVN-001 in chronic myeloid leukemia.
• Selina Hospitality PLC SLNA rose 21.1% to $0.0923.
• Globavend Holdings Limited GVH climbed 16.8% to $1.68.
• Janux Therapeutics, Inc. JANX gained 16.8% to $52.15 following Wednesday reports suggesting the company is said to weigh a possible sale.
• SciSparc Ltd. SPRC shares rose 15.3% to $1.9357.
• Gyre Therapeutics, Inc. GYRE gained 14.6% to $15.91.
• AnaptysBio, Inc. ANAB climbed 11.4% to $24.72. Wells Fargo analyst Derek Archila initiated coverage on AnaptysBio with an Overweight rating and announced a price target of $56.
• Verb Technology Company, Inc. VERB gained 10.4% to $0.2010 after gaining 4% on Wednesday.
• GigaCloud Technology Inc. GCT rose 10.2% to $34.18.
• Nurix Therapeutics, Inc. NRIX gained 9.6% to $17.21. Baird analyst Joel Beatty maintained Nurix Therapeutics with an Outperform and raised the price target from $24 to $25.
• StepStone Group LP STEP rose 7.1% to $37.46 after JP Morgan upgraded the stock from Neutral to Overweight.

Losers

• Aptevo Therapeutics Inc. APVO shares fell 58% to $1.01 after the company priced its $4.6 million public offering.
• Enlivex Therapeutics Ltd. ENLV fell 54.5% to $1.81. The company announced topline results of its Phase II trial evaluating Allocetra in sepsis.
• AVITA Medical, Inc. RCEL fell 28.6% to $10.31 after the company announced an update to its expected commercial revenue for the first quarter of 2024. BTIG downgraded the stock from Buy to Neutral.
• Aesthetic Medical International Holdings Group Limited AIH fell 19% to $0.3723.
• Globe Life Inc. GL fell 14.6% to $89.65.
• The Lovesac Company LOVE shares fell 14.3% to $20.00 after the company reported worse-than-expected fourth-quarter results and issued first-quarter guidance.
• Globe Life Inc. GL fell 13.7% to $90.56.
• Meiwu Technology Company Limited WNW shares declined 12.4% to $1.1601 after jumping around 32% on Wednesday.
• Acorda Therapeutics, Inc. ACOR fell 12% to $0.7660 after declining 14% on Wednesday. Acorda Therapeutics recently commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.
• CarMax, Inc. KMX fell 11.7% to $70.02 after the company reported lower-than-expected fourth-quarter earnings.
• VBI Vaccines Inc. VBIV dipped 11.3% to $0.5641.
• Nikola Corporation NKLA fell 11.3% to $0.8680. On April 9, Wolfe Research analyst Scott Group initiated coverage on Nikola with a Peer Perform rating.
• Marin Software Incorporated MRIN declined 10.8% to $0.5798.
• SolarBank Corporation SUUN fell 9.3% to $5.29. SolarBank closed purchase of 3.15 MW solar project in New York from Storke Renewable.
• Esperion Therapeutics, Inc. ESPR fell 9.1% to $2.29.
• 9F Inc. JFU fell 8.8% to $2.7046.
• iCoreConnect Inc. ICCT shares fell 8.5% to $1.55 after jumping over 50% on Wednesday.
• ClearOne, Inc. CLRO declined 8.3% to $1.00. The company recently reported fourth-quarter financial results.
• Nyxoah S.A. NYXH fell 7.3% to $9.83
• Acorda Therapeutics, Inc. ACOR fell 6.2% to $0.8164.
• Walker & Dunlop, Inc. WD fell 5.3% to $87.71 after Wedbush downgraded the stock from Outperform to Neutral and lowered its price target from $130 to $95.

Now Read This: Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter